Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone versus micronized progesterone for threatened abortion
IRCT20120104008611N10Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in threatened abortion comparing Micronized progesterone with Dydrogesterone (2 arms). Primary endpoints: Preeclampsia, Gestational diabetes and 3 more. Started Oct 2019; status: completed.
02
Drugs
dydrogesteroneprogesterone
03
Conditions
threatened abortion
Beyond the preview
Go deeper on IRCT20120104008611N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120104008611N10.